Drawing for LENICURA

USPTO serial 79192493

LENICURA

Reviewed by CopyMark Law Group

Reg. 5283086Status 707Renewal
Filing date
Status date
Registration date
Sep 12, 2017
Examiner
LUDEMAN, JESSICA ANN
Law office
FILE DESTROYED

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with LENICURA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Steven Walmsley

Steven Walmsley REISING ETHINGTON PC755 West Big Beaver Road, Suite 1850Suite 1850TROY, MI 48084

Goods and services

ClassDescriptionStatusFirst use
010Medical apparatus and instruments for the use in treatment of inflammatory diseases of the skin, the glands, the mucous membranes, the connective tissue, the nerves and the horn tissue and for the use in treatment of hidradenitis suppurativa, acne inversa, abscesses and acne; medical radiation apparatus; electromagnetic wave therapeutic medical instruments for the use in treatment of inflammatory diseases of the skin, the glands, the mucous membranes, the connective tissue, the [ nerves ] and the horn tissue and for the use in treatment of hidradenitis suppurativa, acne inversa, abscesses and acne; visible light treatment medical instruments for the use treatment of inflammatory diseases of the skin, the glands, the mucous membranes, the connective tissue, the [ nerves ] and the horn tissue and for the use in treatment of hidradenitis suppurativa, acne inversa, abscesses and acne; medical skin enhancement apparatus and instruments for the use in treatment of inflammatory diseases of the skin, the glands, the mucous membranes, the connective tissue, the nerves and the horn tissue and for the use in treatment of hidradenitis suppurativa, acne inversa, abscesses and acne; medical apparatus and instruments for the treatment of diseases of the skin, the glands, the mucous membranes, the connective tissue, the nerves and the horn tissue; medical apparatus and instruments for the treatment of hidradenitis suppurativa and acne inversaACTIVE—
037[ Repair and maintenance of medical machines, apparatus and instruments ]SECTION 71 - CANCELLED—
044[ Medical treatment services of inflammatory diseases of the skin, the glands, the mucous membranes, the connective tissue, the nerves and the horn tissue and for the use in treatment of hidradenitis suppurativa, acne inversa, abscesses and acne; cosmetic treatment for the body; medical treatment of the skin; dermatological services for treating skin conditions; medical testing services relating to the diagnosis and treatment of disease; arranging of medical treatment, namely, consulting services in the field of health; cosmetic treatment, namely, providing facial and body treatment services, cosmetic body care services; medical services in the nature of therapeutic treatment of the skin, the glands, the mucous membranes, the connective tissue, the nerves and the horn tissue; medical services in the nature of therapeutic treatment of hidradenitis suppurativa and acne inversa ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 12, 2026REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
May 28, 2026RNWLINTERNATIONAL REGISTRATION RENEWED—
May 3, 2025INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Apr 13, 2025INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Apr 12, 2025INPCINVALIDATION PROCESSED—
Jan 24, 2025INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
May 24, 2024NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
May 24, 202471.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
May 6, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 7, 2023ES71TEAS SECTION 71 RECEIVED—
Sep 12, 2022REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jul 2, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 18, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 24, 2018TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 26, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 19, 2017FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 19, 2017FIMPFINAL DISPOSITION PROCESSED—
Dec 12, 2017FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 12, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 27, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 7, 2017NPUBNOTICE OF PUBLICATION—
May 19, 2017PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 19, 2017CNEAEXAMINERS AMENDMENT MAILED—
May 19, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 19, 2017XAECEXAMINER'S AMENDMENT ENTERED—
May 19, 2017CNEAEXAMINERS AMENDMENT -WRITTEN—
May 2, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 2, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 1, 2017ALIEASSIGNED TO LIE—
Apr 11, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 10, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 28, 2016RFNTREFUSAL PROCESSED BY IB—
Oct 13, 2016RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 13, 2016RFRRREFUSAL PROCESSED BY MPU—
Oct 7, 2016MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 5, 2016RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 4, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 3, 2016DOCKASSIGNED TO EXAMINER—
Oct 3, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 1, 2016REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance